51. Massive Endocytosis Activated by Perturbing the Outer Plasmalemmal Monolayer
- Author
-
Donald W. Hilgemann, Marc C. Llaguno, Simona Magi, Alp Yaradanakul, Michael Fine, Mei-Jung Lin, and Vincenzo Lariccia
- Subjects
0303 health sciences ,Membrane permeability ,Vesicle ,Endocytic cycle ,Biophysics ,Vacuole ,Biology ,Endocytosis ,03 medical and health sciences ,0302 clinical medicine ,Biochemistry ,Cytoplasm ,Phospholipase inhibitor ,Sphingomyelin ,030217 neurology & neurosurgery ,030304 developmental biology - Abstract
The roles played by lipids in endocytic processes are the subject of much ongoing debate. Using electrophysiological, optical, and ultrastructural methods, we describe massive endocytosis (MEND) of >50% of the plasmalemma in response to perturbing the outer plasmalemma monolayer of fibroblasts and cardiac myocytes by multiple means. Extracellular application of a bacterial sphingomyelinase causes MEND within seconds, and similar responses occur with the nonionic detergents, Triton X-100 and NP-40, proapoptotic drugs (e.g. edelfosine and tamoxifen), and an amphipathic phospholipase inhibitor, U73122. At the concentrations employed, the effective agents do not cause membrane permeability changes, and they are inactive from the cytoplasmic side. Ca transients that do not cause MEND decrease markedly the threshold concentrations of amphipaths that cause MEND, perhaps by generating a lipid catalyst of MEND. Noise analysis of NP-40 records suggests that the average vesicle size is initially small (
- Published
- 2010
- Full Text
- View/download PDF